These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2550779)

  • 1. Growth of S49 cells in low concentrations of beta-adrenergic agonists causes desensitization.
    Barber R; Goka TJ; Butcher RW
    Mol Pharmacol; 1989 Sep; 36(3):459-64. PubMed ID: 2550779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-adrenergic receptor levels and function after growth of S49 lymphoma cells in low concentrations of epinephrine.
    Proll MA; Clark RB; Goka TJ; Barber R; Butcher RW
    Mol Pharmacol; 1992 Jul; 42(1):116-22. PubMed ID: 1321952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positively cooperative cAMP phosphodiesterase attenuates cellular cAMP responses.
    Barber R; Goka TJ; Butcher RW
    Second Messengers Phosphoproteins; 1992; 14(1-2):77-97. PubMed ID: 1383507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. cAMP-dependent protein kinase responses of S49 cells are reduced by growth in low epinephrine concentrations.
    Prashad N; Goka TJ; Barber R; Butcher RW
    Mol Pharmacol; 1990 Jun; 37(6):937-42. PubMed ID: 2163019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. cAMP metabolism in an S49 mouse lymphoma variant with diminished phosphodiesterase activity.
    Butcher RW; Barber R; Goka TJ
    J Cyclic Nucleotide Protein Phosphor Res; 1986; 11(4):275-90. PubMed ID: 3025277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phorbol ester-induced augmentation and inhibition of epinephrine-stimulated adenylate cyclase in S49 lymphoma cells.
    Johnson JA; Goka TJ; Clark RB
    J Cyclic Nucleotide Protein Phosphor Res; 1986; 11(3):199-215. PubMed ID: 3020100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta 2-adrenergic receptor mutants reveal structural requirements for the desensitization observed with long-term epinephrine treatment.
    Proll MA; Clark RB; Butcher RW
    Mol Pharmacol; 1993 Sep; 44(3):569-74. PubMed ID: 8396717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple mechanisms for desensitization of A2a adenosine receptor-mediated cAMP elevation in rat pheochromocytoma PC12 cells.
    Chern Y; Lai HL; Fong JC; Liang Y
    Mol Pharmacol; 1993 Nov; 44(5):950-8. PubMed ID: 8246918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of ornithine decarboxylase and S-adenosylmethionine decarboxylase activities of S49 lymphoma cells by agents increasing cyclic AMP.
    Honeysett JM; Insel PA
    J Cyclic Nucleotide Res; 1981; 7(5):321-32. PubMed ID: 6284819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epinephrine desensitization of adenylate cyclase from cyc- and S49 cultured lymphoma cells.
    Green DA; Friedman J; Clark RB
    J Cyclic Nucleotide Res; 1981; 7(3):161-72. PubMed ID: 7287968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epinephrine-induced sequestration of the beta-adrenergic receptor in cultured S49 WT and cyc- lymphoma cells.
    Clark RB; Friedman J; Prashad N; Ruoho AE
    J Cyclic Nucleotide Protein Phosphor Res; 1985; 10(1):97-119. PubMed ID: 2984267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of a bromoacetylated derivative of pindolol as a high affinity, irreversible beta adrenergic antagonist in cultured cells.
    Jasper JR; Motulsky HJ; Insel PA
    J Pharmacol Exp Ther; 1988 Mar; 244(3):820-4. PubMed ID: 2908047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth of S49 wild type cells in 3 nM epinephrine increases cyclic AMP phosphodiesterase activity.
    Richardson MD; Goka TJ; Barber R; Butcher RW
    Life Sci; 1994; 54(13):863-75. PubMed ID: 8139375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Agonist-induced changes in the properties of beta-adrenergic receptors on intact S49 lymphoma cells. Time-dependent changes in the affinity of the receptor for agonists.
    Hoyer D; Reynolds EE; Molinoff PB
    Mol Pharmacol; 1984 Mar; 25(2):209-18. PubMed ID: 6142414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uncoupling of the beta-adrenergic receptor as a mechanism of in vitro neutrophil desensitization.
    Galant SP; Britt S
    J Lab Clin Med; 1984 Feb; 103(2):322-32. PubMed ID: 6319518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic somatostatin treatment induces enhanced forskolin-stimulated cAMP accumulation in wild-type S49 mouse lymphoma cells but not in protein kinase-deficient mutants.
    Thomas JM; Hoffman BB
    Mol Pharmacol; 1989 Jan; 35(1):116-24. PubMed ID: 2563303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for the role of epinephrine binding frequency in activation of adenylate cyclase.
    Stickle D; Barber R
    Mol Pharmacol; 1989 Sep; 36(3):437-45. PubMed ID: 2550777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Desensitization of beta-adrenergic receptor-mediated vascular smooth muscle relaxation.
    Tsujimoto G; Hoffman BB
    Mol Pharmacol; 1985 Feb; 27(2):210-7. PubMed ID: 2578603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of agonist stimulation of cAMP-dependent protein kinase and G protein-coupled receptor kinase phosphorylation of the beta2-adrenergic receptor using phosphoserine-specific antibodies.
    Tran TM; Friedman J; Qunaibi E; Baameur F; Moore RH; Clark RB
    Mol Pharmacol; 2004 Jan; 65(1):196-206. PubMed ID: 14722251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Desensitization in rat parotid to beta-adrenergic agonists and counteracting effects of forskolin are conserved in membrane and detergent-solubilized adenylate cyclase catalyst activity.
    Harper JF
    J Cyclic Nucleotide Protein Phosphor Res; 1986; 11(3):167-76. PubMed ID: 2876014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.